The Innovator IBD 50 ETF is headed for a week of outstanding gains. Three stocks in the ETF are near buy points.

Schrodinger stock earned a positive adjustment to its Relative Strength (RS) Rating, from 66 to 73. Please watch the video at ...

Royal Caribbean announces 36% dividend hike, $1 billion share repurchase plan. RCL stock looks to retake a buy point.

Patients with inflammatory bowel disease remain at higher risk for mental health disorders, but training support staff to ...

In a recent study published in the Journal of Crohn’s and Colitis, researchers showed that oral vancomycin (OV) induces ...

Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...

The most common reason for delaying or not receiving care was not getting an appointment when they needed one, cited by 39% of respondents. More than half (56%) of patients reported delays in ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

Past research shows that it can be challenging to detect pre-cancerous cells in people with IBD. Researchers from The ...

Queensland has the third highest prevalence of a debilitating bowel disease that impacts 180,000 Australians, costing ...

A recent major OECD report has warned of a looming crisis in the European health workforce. In the third in our series on the ...